Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
Supply Chain Delaying Covid-19 vaccine booster rooted in some clinical data versus reducing doses, but neither approach likely to solve distribution quandaries 27 Jan 2021
Lynparza lowers death risk in Phase III prostate cancer trial AstraZeneca and MSD partnered in July 2017 to jointly develop and commercialise Lynparza for various cancers. Credit: © AstraZeneca.
